Pharmacy Disclosure Log 2020

 

1. Acromegaly Response 5532
2. Anti-VEGF Treatments Response 5523
3. Antiretroviral Therapies Response 5560
4. Anit VEGF Treatment Response 5329
5. Biologics & Biosimilar Prescribing in Rheumatology Response 5093
6. Biologics and Biosimilar Products Response 5428
7. Breast Cancer Treatment Response 5445
8. Dermatology Treatment Response 5553
9. Dermatology Treatment Response 5440
10. Dermatology Biologics Response 5140
11. Dispensed Products Response 5256
12. Delirium Response 5373
13. Delirium Response 5373 - Attachment
14. Free of Charge Medication Response 5379
15. Gastro Biologics Response 5124
16. Intra-Vitreal Injections or Implants Response 5303
17. Ophthalmology Prescribing Response 5201
18. Osteoporosis Treatment Response 5250
19. Oesophageal Cancer Response 5559
20. Medication Response 5390
21. Patients being Treated for Metastatic Non-Small-Cell Lung Cancer Response 5313
22. Patients being Treated for Metastatic Non-Small-Cell Lung Cancer Response 5313 - Attachment
23. Patient Group Directive Response 5152
24. Patients Treated for Asthma Response 5249
25. Patients Treated with Specific Drugs Response 5282
26. Patients Treated for Colorectal Cancer Response 5283
27. Patients Treated with Specific Drugs Response 5319
28. Patients Treated for Colorectal Cancer Response 5283 - Attachment
29. Patients Treated for Severe Asthma Response 5383
30. Patients Treated with Specific Drugs Response 5387
31. Prescriptions of Unlicensed Cannabis based Medical Products Response 5463
32. Prescribing regardless of Diagnosis Response 5262
33. Prescribing Data for CBPMs Response 5098
34. Treatment of Lung and Urothelial Cancer Response 5459
35. Treatment of Lung and Urothelial Cancer Response 5459 Attachment
36. ULMs and UK Unlicensed Specials Response 5142
37. ULMs and UK Unlicensed Specials Response 5142 Attachment
38. Usage Sodium Chloride 5% Response 5121

• Share:
• Facebook
• Twitter
• LinkedIn